Caffeine can be a legal way to enhance athletic performance, though studies have shown mixed results. Genetic variation may be the reason caffeine does not work the same for everyone.

Many studies have shown that caffeine can increase a person’s athletic performance, but these studies have also shown that these effects are not universal throughout the participants.

A new study examines the link between caffeine’s effects and genetic differences between people.

Dr. Christopher J. Womack...

Melanoma, one of the most common cancers affecting Americans, casts a shadow over people at risk for this disease. However researchers are finding new ways to lower melanoma rates.

A recent cohort study examining the use of vitamin A supplements provided evidence that may help researchers find ways to reduce melanoma rates among high-risk populations

The author of this study was Maryam

Researchers from Taiwan published a study showing that statin use substantially reduced risk of gastric cancer. Could smoked fish be the reason?

Every pregnant mom wants to receive quality care from doctors and nurses. According to a new study, delivering your baby at a hospital that’s recognized for nursing excellence can impact your baby’s health.

Researchers from the University of Pennsylvania School of Nursing studied more than 72,000 very low-birth-weight (VLBW) infants (less than 3.3 pounds at birth).  

They found that that babies born at hospitals recognized for nursing excellence (RNE) were less...

Chemotherapy, surgery, radiation. The choice used to be simple, but doctors are taking a closer look at combination therapy, using elements of several treatments for the best outcome.

The medication Stendra (avanafil) has just been approved by the U.S. Food and Drug Administration to treat erectile dysfunction, the FDA announced today.

A new drug under development for the treatment of the childhood leukemia T-ALL has had success in the first round of pharmaceutical testing.

An experimental new drug known as CAL-130 is a dual enzyme inhibitor, blocking two forms of an enzyme used in the out of control growth involved in leukemia.

The drug successfully stopped the enzymes phosphoinositide-3 kinase gamma and delta in testing, effectively stopping cancer growth.

It's well known that osteoporosis is most common among post-menopausal women. A new study finds that women who start menopause early are at greater risk for fracture than most women.

In fact, women who go through menopause before they turn 48 are twice as likely to develop osteoporosis, a disease that weakens bones and leads to fractures.

The average age for menopause to start is 51.

The study was conducted by Swedish researchers and published in

The inflammation response is used by the body to signal an attack, but it turns out in at least one kind of melanoma, the cancer uses the same signal to go into hiding.

It's a common concept. If one dose works well, then two doses may work even better. This theory was tested recently in patients being treated for chronic myeloid leukemia (CML), and it didn't work.